PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $354,000 | +2.6% | 400,000 | 0.0% | 0.09% | +17.8% |
| Q2 2022 | $345,000 | -2.5% | 400,000 | 0.0% | 0.07% | +19.7% |
| Q1 2022 | $354,000 | -3.3% | 400,000 | 0.0% | 0.06% | +17.3% |
| Q4 2021 | $366,000 | +3.7% | 400,000 | 0.0% | 0.05% | +2.0% |
| Q3 2021 | $353,000 | -1.1% | 400,000 | 0.0% | 0.05% | +6.2% |
| Q2 2021 | $357,000 | -0.3% | 400,000 | 0.0% | 0.05% | -5.9% |
| Q1 2021 | $358,000 | +3.2% | 400,000 | 0.0% | 0.05% | +4.1% |
| Q4 2020 | $347,000 | +5.5% | 400,000 | 0.0% | 0.05% | -14.0% |
| Q3 2020 | $329,000 | +1.9% | 400,000 | 0.0% | 0.06% | +9.6% |
| Q2 2020 | $323,000 | +22.8% | 400,000 | 0.0% | 0.05% | +20.9% |
| Q1 2020 | $263,000 | -8.0% | 400,000 | 0.0% | 0.04% | +48.3% |
| Q4 2019 | $286,000 | +2.1% | 400,000 | 0.0% | 0.03% | +3.6% |
| Q3 2019 | $280,000 | +2.6% | 400,000 | 0.0% | 0.03% | +7.7% |
| Q2 2019 | $273,000 | – | 400,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $22,713,000 | 5.56% |
| SILVERBACK ASSET MANAGEMENT LLC | 7,707,000 | $6,912,000 | 0.94% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,615,000 | $31,948,000 | 0.74% |
| DeepCurrents Investment Group LLC | 12,521,000 | $11,079,000 | 0.34% |
| AGF Investments LLC | 4,000,000 | $3,502,000 | 0.29% |
| WATER ISLAND CAPITAL LLC | 2,250,000 | $2,014,000 | 0.10% |
| L & S Advisors Inc | 935,000 | $829,000 | 0.10% |
| Sculati Wealth Management, LLC | 200,000 | $177,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,192,000 | $2,816,000 | 0.06% |
| Teton Advisors, Inc. | 400,000 | $354,000 | 0.06% |